National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Latest Drugs
Latanoprost/Timolol (Fixapost®) HTA ID: 21053 -
December 6, 2021
Tirbanibulin (Klisyri®). HTA ID: 21054 -
November 30, 2021
Dostarlimab (Jemperli®). HTA ID: 21045 -
November 30, 2021
Nivolumab (Opdivo®) for advanced or metastatic gastric, gastro oesophageal junction or oesophageal adenocarcinoma (1L). HTA ID: 21049. -
November 29, 2021
Tildrakizumab (Ilumetri®). HTA ID: 19029 -
November 25, 2021
Larotrectinib (Vitrakvi ®) HTA ID: 19050 -
November 23, 2021
Zanubrutinib (Brukinsa®). HTA ID: 21044 -
November 16, 2021
Daratumumab (Darzalex®) HTA ID: 20025 -
November 16, 2021
Bempedoic acid/Ezetimibe (Nustendi®) HTA ID: 20026b -
November 16, 2021
Bempedoic acid (Nilemdo®) HTA ID: 20026a -
November 16, 2021
1
2
3
4
5
6
7
8
9
10
...
20
30
40
...
Next Page
Last »
health check
©2021 National Centre for Pharmacoeconomics
